CD38 and acute lymphoblastic leukemia: In contrast, for the other two T-ALL patients (XB37, XB47) very few mutations were detected in the CD34+CD38− cells and myeloid progenitor cells, indicating that the majority of these mutations were acquired in progenitors already committed to the lymphoid lineage (Fig. 5b).